Prospeo
Hero Section BackgroundHero Section Background
NephroDI Therapeutics

NephroDI Therapeutics

Biotechnology ResearchFlag of USSeattle, Washington, United States1-10 Employees

Company overview

Headquarters2200 32nd Ave W, Seattle, Washington 98199, US
Phone number+12066960546
Website
NAICS541714
Employees1-10
Socials

Key Contact at NephroDI Therapeutics

Flag of US

Dennis Rose

Vice President Operations

NephroDI Therapeutics Email Formats

NephroDI Therapeutics uses 1 email format. The most common is {first initial}{last name} (e.g., jdoe@nephrodi.com), used 100% of the time.

FormatExamplePercentage
{first initial}{last name}
jdoe@nephrodi.com
100%

About NephroDI Therapeutics

NephroDI Therapeutics is a clinical stage biopharmaceutical company that focuses on concentration disorders of the kidney. The initial clinical indication for its orally administered lead small molecule is for Nephrogenic Diabetes Insipidus in children, a pediatric orphan indication. Nephrogenic Diabetes Insipidus (NDI) is a disease where patients produce extremely large amounts of dilute urine resulting from an inability of the kidney to respond to vasopressin. Congenital NDI in the pediatric population results primarily from mutations in the type 2 vasopressin receptor, which is located on the X chromosome. Congenital NDI has a profound impact on children. Since these children can produce up to 20 L of urine per day, They must drink 20 L (80 8oz glasses) of water per day to avoid dehydration. Children who suffer multiple episodes of severe dehydration often end up with mental retardation. For more information visit www.nephrodi.com

$

NephroDI Therapeutics revenue & valuation

Annual revenue$598,885
Revenue per employee$86,000
Estimated valuation?$2,000,000
Total funding$5,200,000

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite
Entry
Vice President

Employees by Department

NephroDI Therapeutics has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Explore NephroDI Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date
Round
Amount
Link to Article
2021-03-231$1,600,000
2021-03-233$1,600,000
2024-07-111$2,000,000

Funding Insights

$5,200,000

Total funding amount

$2,000,000

Most recent funding amount

3

Number of funding rounds

NephroDI Therapeutics Tech Stack

Discover the technologies and tools that power NephroDI Therapeutics's digital infrastructure, from frameworks to analytics platforms.

Cloudflare

Cloudflare

CDN

reCAPTCHA

reCAPTCHA

Security

jQuery

jQuery

JavaScript libraries

FlyingPress

FlyingPress

Performance

GoDaddy

GoDaddy

Hosting

Google Tag Manager

Google Tag Manager

Tag managers

HTTP/3

HTTP/3

Miscellaneous

PHP

PHP

Programming languages

WordPress

WordPress

Blogs

Kinsta

Kinsta

Hosting

Divi

Divi

Page builders

jQuery Mobile

jQuery Mobile

Mobile frameworks

Frequently asked questions

NephroDI Therapeutics is located in Seattle, Washington, US.
You can reach NephroDI Therapeutics at +12066960546.
NephroDI Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
NephroDI Therapeutics has raised a total of $5,200,000 across 3 funding rounds. This investment has helped the company grow and expand its operations.

4.8

40,000 users

top 50
high performer
most used
tier 1 accuracy

Build leads list with verified emails & mobiles